Global tuberculosis report 2012
http://www.who.int/tb/publications/global_report/en/index.html
This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.

Peter D Davies, Peeter Barnes, Stephen B Gordon
"Clinical Tuberculosis"
Oxford University Press | 2008 | ISBN: 034094840X | 670 pages

Clinical Tuberculosis remains an indispensable resource for respiratory physicians, infectious disease specialists, public health workers and other individuals involved in the management and control of tuberculosis worldwide. This established reference is a comprehensive accoutn of tuberculosis, providing up-to-date and authoritative information on all aspects of the disease. It gives practical guidance to health professionals who may be involved in any aspect of patient management or disease control, including chapters on epidemiology, pathology, immunology, disease presentation, diagnosis, treatment and management options. Specific consideration is given to the problems of TB associated with HIV infection, and issues of control relating to low and high prevalence countries respectively. The ongoing issues surrounding the BCG vaccination and preventive therapy are also covered, as are the increasing problems of multi-drug resistant strains and environmental opportunist mycobacteria.

Henry Wouk, "Tuberculosis (Health Alert)"
English | ISBN: 076143979X | 2009 | 68 pages

Provides comprehensive information on the causes, treatment, and history of tuberculosis.

AIDS and Tuberculosis: A Deadly Liaison
English | 2009 | ISBN: 3527322701 | 320 pages

The immune deficiency AIDS leads to a drastic increase in susceptibility to Tuberculosis.

Tuberculosis: The White Plague! By Miriam Aronin
2010 | 36 Pages | ISBN: 1936088061

Oswaldo Juarez, a 19-year-old student in Florida, had been feeling ill for a few weeks. Then, on a fall night in 2007, he began to cough up blood. As he looked at the red stain in his sink, he thought he might be dying. He raced to a doctor to have tests done to find out what was wrong with him.
Then came the terrible news. Oswaldo had tuberculosis, or TB—a disease that kills more than one million people on Earth every year. How does this killer disease spread to so many people? Look inside to find out more about Oswaldo and other victims of tuberculosis. You’ll also discover what causes the dangerous illness, how it affects the body, and—most important—how to protect yourself from it in the first place.

"Understanding Tuberculosis - New Approaches to Fighting Against Drug Resistance" ed. by Pere-Joan Cardona
InTeO | 2012 | ISBN: 9533079486 9789533079486 | 385 pages

In this book, diverse authors focus on the development and the activity of the new tuberculosis drug families.

In 1957, a Streptomyces strain, the ME/83 (S.mediterranei), was isolated in the Lepetit Research Laboratories from a soil sample collected at a pine arboretum near Saint Raphael, France. This drug was the base for the chemotherapy with Streptomicine. The euphoria generated by the success of this regimen lead to the idea that TB eradication would be possible by the year 2000.
Thus, any further drug development against TB was stopped. Unfortunately, the lack of an accurate administration of these drugs originated the irruption of the drug resistance in Mycobacterium tuberculosis. Once the global emergency was declared in 1993, seeking out new drugs became urgent.

Contents
Preface
Part 1 Strategies for new drug discovering
1 Multi-Drug/Extensively Drug Resistant Tuberculosis (Mdr/Xdr-Tb): Renewed Global Battle Against Tuberculosis?
2 Chemotherapeutic Strategies and Targets Against Resistant TB
3 A New Hope in TB Treatment: The Development of the Newest Drugs
4 In Search of El Dorado: Current Trends and Strategies in the Development of Novel Anti-Tubercular Drugs
5 An Approach to the Search for New Drugs Against Tuberculosis
6 Antitubercular In Vitro Drug Discovery: Tools for Begin the Search
7 New Antitubercular Drugs Designed by Molecular Modification
8 The Cord Factor: Structure, Biosynthesis and Application in Drug Research - Achilles Heel of Mycobacterium tuberculosis?
Part 2 New drugs to face Resistance
9 Old and New TB Drugs: Mechanisms of Action and Resistance
10 Pyrazinecarboxylic Acid Derivatives with Anti mycobacteria I Activity
11 The Potential Therapeutic Usage of Dithiocarbamate Sugar Derivatives for Multi-Drug Resistant Tuberculosis
12 Fighting Against Resistant Strains: The Case of Benzothiazinones and Dinitrobenzamides
13 Quinolone Resistance in Tuberculosis Treatment: A Structural Overview
14 Anti mycobacteria I Activity Some Different Lamiaceae Plant Extracts Containing Flavonoids and Other Phenolic Compounds
15 Cinnamic Derivatives in Tuberculosis
16 Potential Use of I. suffruticosa in Treatment of Tuberculosis with Immune System Activation

"Understanding Tuberculosis - Global Experiences and Innovative Approaches to the Diagnosis" ed. by Pere-Joan Cardona
InTeO | 2012 | ISBN: 9533079387 9789533079387 | 562 pages

This book presents the experience of worldwide specialists on the tuberculosis diagnosis, along with its lights and shadows.

Mycobacterium tuberculosis is a disease that is transmitted through aerosol. This is the reason why it is estimated that a third of humankind is already infected by Mycobacterium tuberculosis. The vast majority of the infected do not know about their status. Mycobacterium tuberculosis is a silent pathogen, causing no symptomatology at all during the infection. In addition, infected people cannot cause further infections. Unfortunately, an estimated 10 per cent of the infected population has the probability to develop the disease, making it very difficult to eradicate. Once in this stage, the bacilli can be transmitted to other persons and the development of clinical symptoms is very progressive.
Therefore the diagnosis, especially the discrimination between infection and disease, is a real challenge.

Contents
Part 1 Experience on Laboratory diagnosis around the World
1 Clinical Laboratory Diagnostics for Mycobacterium tuberculosis
2 Laboratory Diagnosis of Latent and Active Tuberculosis Infections in Trinidad a Tobago and Determination of Drug Susceptibility Profile of Tuberculosis Isolates in the Caribbean
3 Tuberculosis is Still a Major Challenge in Africa
4 Tuberculosis in Saudi Arabia
5 Diagnosis of Mycobacterium tuberculosis
6 Diagnosis of Smear-Negative Pulmonary Tuberculosis in Low-Income Countries: Current Evidence in Sub-Saharan Africa with Special Focus on HIV Infection or AIDS
7 Immunologic Diagnosis of Neurotuberculosis
8 Diagnostic Methods for Mycobacterium tuberculosis and Challenges in Its Detection in India
9 Management of TB in HIV Subjects, the Experience in Thailand
10 Mycobacterium tuberculosis: Biorisk, Biosafety and Biocontainment
Part 2 New approaches to the TB diagnosis
11 New Diagnostics for Mycobacterium tuberculosis
12 Nanodiagnostics for Tuberculosis
13 Sputum Smear Microscopy for Tuberculosis: Eval uation of Autofocus Functions and Automatic Identification of Tuberculosis Mycobacterium
14 The Use of Phage for Detection, Antibiotic Sensitivity Testing and Enumeration
15 Molecular Imaging in TB: From the Bench to the Clinic
16 Data Mining Techniques in the Diagnosis of Tuberculosis
17 Immunological Diagnosis of Active and Latent TB
18 Immune Diagnosis of Tuberculosis Through Novel Technologies
19 Exosomes: New Tuberculosis Bio markers - Prospects From the Bench to the Clinic
20 Molecular Techniques for Identification of Species of the Mycobacterium tuberculosis Complex: The use of Multiplex PCR and an Adapted HPLC Method for Identification of Mycobacterium bovis and Diagnosis of Bovine Tuberculosis
Part 3 Improving detection and control of resistances
21 Survey and Molecular Characterization of Drug- Resistant M. tuberculosis Clinical Isolates from Zunyi, Guizhou Province of China
22 Molecular Biological Techniques for Detection of Multidrug Resistant Tuberculosis (MDR) and Extremely Drug Resistant Tuberculosis (XDR) in Clinical Isolates of Mycobacterium tuberculosis
23 Detection of Mycobacterium tuberculosis and Drug Resistance: Opportunies and Challenges in Morocco
24 Pattern of Circulating Mycobacterium tuberculosis Strains in Sri Lanka
25 Health Interventions to Improve the Medication Efficacy in Tuberculosis Treatment